ADHD Treatments, Sleep, and Sleep Problems: Complex Associations
ADHD, sleep, and ADHD treatments are highly interrelated. In this review, we describe the effects of stimulants and non stimulant medications on sleep in children, adolescents, and adults with ADHD. Clinical predictors of sleep problems during pharmacotherapy include age, sleep problems prior to ini...
Gespeichert in:
| Veröffentlicht in: | Neurotherapeutics 2012-07, Vol.9 (3), p.509-517 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 517 |
|---|---|
| container_issue | 3 |
| container_start_page | 509 |
| container_title | Neurotherapeutics |
| container_volume | 9 |
| creator | Stein, Mark A. Weiss, Margaret Hlavaty, Laura |
| description | ADHD, sleep, and ADHD treatments are highly interrelated. In this review, we describe the effects of stimulants and non stimulant medications on sleep in children, adolescents, and adults with ADHD. Clinical predictors of sleep problems during pharmacotherapy include age, sleep problems prior to initiating treatment, and dose and dosing schedule. As yet, we have little understanding of the biological or genetic factors related to individual variation in drug response and sleep. |
| doi_str_mv | 10.1007/s13311-012-0130-0 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3441938</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3025832241</sourcerecordid><originalsourceid>FETCH-LOGICAL-c470t-ccb61ca2a26b6daf4e9adb8b270ec012b2dabdec136a7cc8143b46c3ae4ed3833</originalsourceid><addsrcrecordid>eNp1kEFLAzEQhYMotlZ_gBdZ8NrVTBI3WQ9iadUKgoL1HJJsWrfsbmqyFf33RrYWPXgIGZg3b958CB0DPgOM-XkASgFSDCQ-ilO8g_oguEg54_lurHNKU06A9tBBCEuMLyjNxT7qEcJBYC766Ho0mU6SmbeqrW3ThmHyXFm7GiaqKboyefJOV7YOl8nY1avKfiSjEJwpVVu6Jhyivbmqgj3a_AP0cnszG0_Th8e7-_HoITWM4zY1RmdgFFEk01mh5szmqtBCE46tiQdoUihdWAM0U9wYAYxqlhmqLLMFFZQO0FXnu1rr2hYmhvWqkitf1sp_SqdK-bfTlK9y4d4lZSxyENHgdGPg3dvahlYu3do3MbMEBgAE-AVEFXQq410I3s63GwDLb-iygy5jZvkNXeI4c_I72nbih3IUkE4QYqtZWP9r9b-uXy2AjTM</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1411121751</pqid></control><display><type>article</type><title>ADHD Treatments, Sleep, and Sleep Problems: Complex Associations</title><source>MEDLINE</source><source>SpringerNature Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Stein, Mark A. ; Weiss, Margaret ; Hlavaty, Laura</creator><creatorcontrib>Stein, Mark A. ; Weiss, Margaret ; Hlavaty, Laura</creatorcontrib><description>ADHD, sleep, and ADHD treatments are highly interrelated. In this review, we describe the effects of stimulants and non stimulant medications on sleep in children, adolescents, and adults with ADHD. Clinical predictors of sleep problems during pharmacotherapy include age, sleep problems prior to initiating treatment, and dose and dosing schedule. As yet, we have little understanding of the biological or genetic factors related to individual variation in drug response and sleep.</description><identifier>ISSN: 1933-7213</identifier><identifier>ISSN: 1878-7479</identifier><identifier>EISSN: 1878-7479</identifier><identifier>DOI: 10.1007/s13311-012-0130-0</identifier><identifier>PMID: 22718078</identifier><language>eng</language><publisher>New York: Springer-Verlag</publisher><subject>Adrenergic alpha-2 Receptor Agonists - adverse effects ; Adrenergic Uptake Inhibitors - adverse effects ; Antipsychotic Agents - adverse effects ; Atomoxetine Hydrochloride ; Attention Deficit Disorder with Hyperactivity - complications ; Attention Deficit Disorder with Hyperactivity - drug therapy ; Attention Deficit Disorder with Hyperactivity - epidemiology ; Attention deficit hyperactivity disorder ; Biomedical and Life Sciences ; Biomedicine ; Central Nervous System Stimulants - adverse effects ; Drug therapy ; Humans ; Insomnia ; Melatonin ; Neurobiology ; Neurology ; Neurosciences ; Neurosurgery ; Propylamines - adverse effects ; Questionnaires ; Review ; Sleep - drug effects ; Sleep disorders ; Sleep Wake Disorders - chemically induced ; Sleep Wake Disorders - epidemiology ; Stimulants</subject><ispartof>Neurotherapeutics, 2012-07, Vol.9 (3), p.509-517</ispartof><rights>The American Society for Experimental NeuroTherapeutics, Inc. 2012</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c470t-ccb61ca2a26b6daf4e9adb8b270ec012b2dabdec136a7cc8143b46c3ae4ed3833</citedby><cites>FETCH-LOGICAL-c470t-ccb61ca2a26b6daf4e9adb8b270ec012b2dabdec136a7cc8143b46c3ae4ed3833</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441938/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441938/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,41488,42557,51319,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22718078$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Stein, Mark A.</creatorcontrib><creatorcontrib>Weiss, Margaret</creatorcontrib><creatorcontrib>Hlavaty, Laura</creatorcontrib><title>ADHD Treatments, Sleep, and Sleep Problems: Complex Associations</title><title>Neurotherapeutics</title><addtitle>Neurotherapeutics</addtitle><addtitle>Neurotherapeutics</addtitle><description>ADHD, sleep, and ADHD treatments are highly interrelated. In this review, we describe the effects of stimulants and non stimulant medications on sleep in children, adolescents, and adults with ADHD. Clinical predictors of sleep problems during pharmacotherapy include age, sleep problems prior to initiating treatment, and dose and dosing schedule. As yet, we have little understanding of the biological or genetic factors related to individual variation in drug response and sleep.</description><subject>Adrenergic alpha-2 Receptor Agonists - adverse effects</subject><subject>Adrenergic Uptake Inhibitors - adverse effects</subject><subject>Antipsychotic Agents - adverse effects</subject><subject>Atomoxetine Hydrochloride</subject><subject>Attention Deficit Disorder with Hyperactivity - complications</subject><subject>Attention Deficit Disorder with Hyperactivity - drug therapy</subject><subject>Attention Deficit Disorder with Hyperactivity - epidemiology</subject><subject>Attention deficit hyperactivity disorder</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Central Nervous System Stimulants - adverse effects</subject><subject>Drug therapy</subject><subject>Humans</subject><subject>Insomnia</subject><subject>Melatonin</subject><subject>Neurobiology</subject><subject>Neurology</subject><subject>Neurosciences</subject><subject>Neurosurgery</subject><subject>Propylamines - adverse effects</subject><subject>Questionnaires</subject><subject>Review</subject><subject>Sleep - drug effects</subject><subject>Sleep disorders</subject><subject>Sleep Wake Disorders - chemically induced</subject><subject>Sleep Wake Disorders - epidemiology</subject><subject>Stimulants</subject><issn>1933-7213</issn><issn>1878-7479</issn><issn>1878-7479</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp1kEFLAzEQhYMotlZ_gBdZ8NrVTBI3WQ9iadUKgoL1HJJsWrfsbmqyFf33RrYWPXgIGZg3b958CB0DPgOM-XkASgFSDCQ-ilO8g_oguEg54_lurHNKU06A9tBBCEuMLyjNxT7qEcJBYC766Ho0mU6SmbeqrW3ThmHyXFm7GiaqKboyefJOV7YOl8nY1avKfiSjEJwpVVu6Jhyivbmqgj3a_AP0cnszG0_Th8e7-_HoITWM4zY1RmdgFFEk01mh5szmqtBCE46tiQdoUihdWAM0U9wYAYxqlhmqLLMFFZQO0FXnu1rr2hYmhvWqkitf1sp_SqdK-bfTlK9y4d4lZSxyENHgdGPg3dvahlYu3do3MbMEBgAE-AVEFXQq410I3s63GwDLb-iygy5jZvkNXeI4c_I72nbih3IUkE4QYqtZWP9r9b-uXy2AjTM</recordid><startdate>20120701</startdate><enddate>20120701</enddate><creator>Stein, Mark A.</creator><creator>Weiss, Margaret</creator><creator>Hlavaty, Laura</creator><general>Springer-Verlag</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>5PM</scope></search><sort><creationdate>20120701</creationdate><title>ADHD Treatments, Sleep, and Sleep Problems: Complex Associations</title><author>Stein, Mark A. ; Weiss, Margaret ; Hlavaty, Laura</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c470t-ccb61ca2a26b6daf4e9adb8b270ec012b2dabdec136a7cc8143b46c3ae4ed3833</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Adrenergic alpha-2 Receptor Agonists - adverse effects</topic><topic>Adrenergic Uptake Inhibitors - adverse effects</topic><topic>Antipsychotic Agents - adverse effects</topic><topic>Atomoxetine Hydrochloride</topic><topic>Attention Deficit Disorder with Hyperactivity - complications</topic><topic>Attention Deficit Disorder with Hyperactivity - drug therapy</topic><topic>Attention Deficit Disorder with Hyperactivity - epidemiology</topic><topic>Attention deficit hyperactivity disorder</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Central Nervous System Stimulants - adverse effects</topic><topic>Drug therapy</topic><topic>Humans</topic><topic>Insomnia</topic><topic>Melatonin</topic><topic>Neurobiology</topic><topic>Neurology</topic><topic>Neurosciences</topic><topic>Neurosurgery</topic><topic>Propylamines - adverse effects</topic><topic>Questionnaires</topic><topic>Review</topic><topic>Sleep - drug effects</topic><topic>Sleep disorders</topic><topic>Sleep Wake Disorders - chemically induced</topic><topic>Sleep Wake Disorders - epidemiology</topic><topic>Stimulants</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Stein, Mark A.</creatorcontrib><creatorcontrib>Weiss, Margaret</creatorcontrib><creatorcontrib>Hlavaty, Laura</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Neurotherapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Stein, Mark A.</au><au>Weiss, Margaret</au><au>Hlavaty, Laura</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>ADHD Treatments, Sleep, and Sleep Problems: Complex Associations</atitle><jtitle>Neurotherapeutics</jtitle><stitle>Neurotherapeutics</stitle><addtitle>Neurotherapeutics</addtitle><date>2012-07-01</date><risdate>2012</risdate><volume>9</volume><issue>3</issue><spage>509</spage><epage>517</epage><pages>509-517</pages><issn>1933-7213</issn><issn>1878-7479</issn><eissn>1878-7479</eissn><abstract>ADHD, sleep, and ADHD treatments are highly interrelated. In this review, we describe the effects of stimulants and non stimulant medications on sleep in children, adolescents, and adults with ADHD. Clinical predictors of sleep problems during pharmacotherapy include age, sleep problems prior to initiating treatment, and dose and dosing schedule. As yet, we have little understanding of the biological or genetic factors related to individual variation in drug response and sleep.</abstract><cop>New York</cop><pub>Springer-Verlag</pub><pmid>22718078</pmid><doi>10.1007/s13311-012-0130-0</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1933-7213 |
| ispartof | Neurotherapeutics, 2012-07, Vol.9 (3), p.509-517 |
| issn | 1933-7213 1878-7479 1878-7479 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3441938 |
| source | MEDLINE; SpringerNature Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central; Alma/SFX Local Collection |
| subjects | Adrenergic alpha-2 Receptor Agonists - adverse effects Adrenergic Uptake Inhibitors - adverse effects Antipsychotic Agents - adverse effects Atomoxetine Hydrochloride Attention Deficit Disorder with Hyperactivity - complications Attention Deficit Disorder with Hyperactivity - drug therapy Attention Deficit Disorder with Hyperactivity - epidemiology Attention deficit hyperactivity disorder Biomedical and Life Sciences Biomedicine Central Nervous System Stimulants - adverse effects Drug therapy Humans Insomnia Melatonin Neurobiology Neurology Neurosciences Neurosurgery Propylamines - adverse effects Questionnaires Review Sleep - drug effects Sleep disorders Sleep Wake Disorders - chemically induced Sleep Wake Disorders - epidemiology Stimulants |
| title | ADHD Treatments, Sleep, and Sleep Problems: Complex Associations |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T12%3A24%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=ADHD%20Treatments,%20Sleep,%20and%20Sleep%20Problems:%20Complex%20Associations&rft.jtitle=Neurotherapeutics&rft.au=Stein,%20Mark%20A.&rft.date=2012-07-01&rft.volume=9&rft.issue=3&rft.spage=509&rft.epage=517&rft.pages=509-517&rft.issn=1933-7213&rft.eissn=1878-7479&rft_id=info:doi/10.1007/s13311-012-0130-0&rft_dat=%3Cproquest_pubme%3E3025832241%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1411121751&rft_id=info:pmid/22718078&rfr_iscdi=true |